ALLE
Allegion PublicBAI scenario view
RankAlpha Sentiment CodexPost-earnings T+1The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The Q3 beat and raised outlook produced a strong positive initial reaction: ALLE closed October 22 at $176.52, up 11.02%. One reported October 23 BofA upgrade and target increase provides an early positive revision signal, but broader analyst and forward-estimate changes are not yet established. The news-sentiment value is a qualitative estimate, not a measured feed score; zero social, options, short-interest and employee values mean unavailable data, not neutral readings. Price history BofA action listing
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Allegion reported Q3 adjusted EPS of $2.60 versus a $2.50 consensus estimate, revenue of $1,172.6 million and 7.2% organic growth. The shares closed up 11.02% on October 22, so much of the immediate surprise appears reflected in the price. [#SEC-8K-2026-10-22] Company earnings release Consensus Price history
Allegion raised its 2026 organic revenue-growth outlook from 3.5%–4.5% to 5.0%–6.0% and adjusted EPS outlook from $8.85–$9.00 to $9.05–$9.10. Delivery depends on continued Americas volume, pricing and productivity gains. December 31 is the fiscal year-end, not a confirmed results date. [#SEC-8K-2026-07-23] [#SEC-8K-2026-10-22] Q3 earnings release
Q3 Americas organic revenue rose 9.1%, led by low-double-digit non-residential growth, while International organic revenue fell 0.2% and its adjusted margin declined 40 basis points to 13.9%. Sustained Americas gains or a recovery abroad would affect the durability of the raised outlook; June 2027 is a monitoring horizon, not a company-announced milestone. [#SEC-8K-2026-10-22] Company earnings release
Recommendation
No formal recommendation provided.

